后发企业提高自主创新能力的路径研究——以恒瑞医药为例

Research on the Paths of Latecomer Firms’ Improvementin Independent Innovation Ability

摘要:

在比较后发企业提高自主创新能力的各路径之间差异性的基础上,具体探讨后发企业提高自主创新能力时具有的优、劣势。并针对恒瑞医药所采取的路径进行分析,具体从政府和企业两方面提出其进一步提高其自主创新能力的对策建议。

Abstract:

On the basis of analyzing the difference between different innovation paths, discussion advantages and disadvantages of latecomer firms improving the independent innovation ability . Finally, in view of the path of Heng Rui Pharmaceuticals choose to improve the capability of independent innovation , the paper proposes suggestions for Heng Rui Pharmaceuticals, in order to improve the independent innovation ability.